49.205 USD
+1.64 (+3.46%)
We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 58 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. While showing a medium growth rate, BRKR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
BRKR had a positive operating cash flow in the past year.
In the past 5 years BRKR has always been profitable.
Each year in the past 5 years BRKR had a positive operating cash flow.
1.2 Ratios
BRKR has a better Return On Assets (-0.37%) than 65.52% of its industry peers.
With a decent Return On Equity value of -0.97%, BRKR is doing good in the industry, outperforming 65.52% of the companies in the same industry.
BRKR has a better Return On Invested Capital (4.01%) than 68.97% of its industry peers.
BRKR had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 13.53%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.99%, BRKR is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR's Gross Margin of 48.00% is in line compared to the rest of the industry. BRKR outperforms 51.72% of its industry peers.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BRKR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.49 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.49) which is in line with its industry peers.
BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, BRKR is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.49 |
ROIC/WACC0.43
WACC9.33%
2.3 Liquidity
BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.85, BRKR is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
BRKR has a Quick Ratio of 1.85. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRKR (0.89) is worse than 87.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.10% in the past year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
The Earnings Per Share is expected to grow by 4.89% on average over the next years.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.60, the valuation of BRKR can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 81.03% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.65. BRKR is around the same levels.
With a Price/Forward Earnings ratio of 21.31, BRKR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 84.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (34.45), we can say BRKR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.6 | ||
| Fwd PE | 21.31 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.04 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.75
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
5. Dividend
5.1 Amount
With a yearly dividend of 0.46%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.49, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.66% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
NASDAQ:BRKR (11/25/2025, 11:14:08 AM)
49.205
+1.64 (+3.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner Change6.36%
Ins Owners26.98%
Ins Owner Change0.17%
Market Cap7.47B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts76.19
Price Target47.46 (-3.55%)
Short Float %13.43%
Short Ratio4.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)3.71%
PT rev (3m)3.33%
EPS NQ rev (1m)-23.81%
EPS NQ rev (3m)-25.12%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)-3.51%
Revenue NQ rev (3m)-3.7%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.6 | ||
| Fwd PE | 21.31 | ||
| P/S | 2.17 | ||
| P/FCF | N/A | ||
| P/OCF | 79.17 | ||
| P/B | 3.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.04 |
EPS(TTM)2
EY4.06%
EPS(NY)2.31
Fwd EY4.69%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.26%
SpS22.67
BVpS16.03
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.75
Graham Number26.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.49 |
F-Score5
WACC9.33%
ROIC/WACC0.43
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.69%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status of BRUKER CORP (BRKR) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP (BRKR) stock?
The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -17.24% in the next year.
Is the dividend of BRUKER CORP sustainable?
The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.